We read with great interest the article by Norvang et al comparing achievement of remission in two different goal‐oriented early rheumatoid arthritis (RA) cohorts [1]. In this study, the ACR/EULAR Boolean remission rates were significantly higher in ARCTIC than in NOR‐VEAC cohort at 3 months, 12 months and 24 months, revealing that adherence to a more stringent definition of remission provided further potential for favorable outcomes. However, some issues should be addressed.

中文翻译：

---

类风湿关节炎治疗目标研究中的缓解分类：对Norvang等人文章的评论。

我们非常感兴趣地阅读了Norvang等人的文章，比较了两个目标明确的早期类风湿关节炎（RA）人群的缓解效果[1]。在这项研究中，在3个月，12个月和24个月时，ARCTIC的ACR / EULAR布尔缓解率显着高于NOR-VEAC队列，这表明坚持更严格的缓解定义为进一步获得有利结果提供了可能性。但是，应该解决一些问题。